Mink TherapeuticsINKT
13F holders, Q1 2025 (March 31)16holders
$8.64avg. 13F price*
At the end of Q1 2025, 16 institutions reported holding Mink Therapeutics Inc. (INKT) in their 13F filings. The largest holders were Vanguard Group Inc. ($205K), Geode Capital Management, LLC ($97K) and BlackRock, Inc. ($76K).
- Company
- Mink Therapeutics Inc.
- CUSIP
- 603693201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $130 |
| Exits | 0 | $0 |
Ownership 16 holders
| Vanguard Group Inc. | 0.00% | Add +4.6% | 23,744 | $205K |
| Geode Capital Management, LLC | 0.00% | Add +20.8% | 11,254 | $97K |
| BlackRock, Inc. | 0.00% | Add +2.6% | 8,778 | $76K |
| Wells Fargo & Company | 0.00% | Reduce -13.2% | 848 | $7K |
| Bank of America Corp. | 0.00% | Add +283.0% | 757 | $7K |
| UBS Group AG | 0.00% | Add +2.9% | 284 | $2K |
| Osaic Holdings, Inc. | 0.00% | Add +86.1% | 238 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -67.2% | 172 | $1K |
| Covestor Ltd | 0.00% | Add +2.3% | 104 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -4.8% | 30 | $259 |
| Morgan Stanley | 0.00% | Reduce -25.9% | 24 | $208 |
| BNP Paribas Financial Markets | 0.00% | Reduce -3.9% | 23 | $199 |
| Northwestern Mutual Wealth Management Co. | 0.00% | Reduce -2.3% | 18 | $156 |
| Game Plan Financial Advisors, LLC | 0.00% | Reduce -2.9% | 16 | $138 |
| Clearstead Advisors, LLC | 0.00% | New | 14 | $121 |
| Jones Financial Companies LLLP | 0.00% | New | 1 | $9 |
"% of holder's portfolio" is INKT's weight in each manager's 13F, not the share of Mink Therapeutics Inc. the manager owns.